Literature DB >> 33020895

Relapse rate and renal prognosis in ANCA-associated vasculitis according to long-term ANCA patterns.

J Oristrell1, J Loureiro-Amigo2, R Solans2, M P Valenzuela3, V Monsálvez1, A Segarra4, M J Amengual5, A Marín6, C Feijoo1, C Tolosa1.   

Abstract

Long-term observation of patients with ANCA-associated vasculitis (AAV) allows the identification of different longitudinal patterns of ANCA levels during follow-up. This study aimed to characterize these patterns and to determine their prognostic significance. All ANCA determinations performed in two university hospitals during a 2-year period were retrospectively reviewed. Patients were included in the analysis if they had high titers of anti-myeloperoxidase (anti-MPO) or anti-proteinase 3 (anti-PR3) antibodies at least once, ≥ 5 serial ANCA determinations and AAV diagnosed by biopsy or American College of Rheumatology (ACR) classification criteria. Patients' time-course ANCA patterns were classified as monophasic, remitting, recurrent or persistent. Associations between ANCA patterns and prognostic variables (relapse rate and renal outcome) were analysed by univariate and multivariate statistics. A total of 99 patients [55 with microscopic polyangiitis (MPA), 36 with granulomatosis with polyangiitis (GPA) and eight with eosinophilic granulomatosis with polyangiitis (EGPA)] were included. Median follow-up was 9 years. Among patients diagnosed with MPA or GPA, recurrent or persistent ANCA patterns were associated with a higher risk of clinical relapse [hazard ratio (HR) = 3·7, 95% confidence interval (CI) = 1·5-9·1 and HR = 2·9, 95% CI = 1·1-8·0, respectively], independently of clinical diagnosis or ANCA specificity. In patients with anti-MPO antibodies, the recurrent ANCA pattern was associated with worsening renal function [odds ratio (OR) = 5·7, 95% CI = 1·2-26·0]. Recurrent or persistent ANCA patterns are associated with a higher risk of clinical relapse. A recurrent ANCA pattern was associated with worsening renal function in anti-MPO-associated vasculitis.
© 2020 British Society for Immunology.

Entities:  

Keywords:  anti-neutrophil cytoplasmic antibodies; prognosis; renal failure; vasculitis

Mesh:

Substances:

Year:  2020        PMID: 33020895      PMCID: PMC7806448          DOI: 10.1111/cei.13530

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  40 in total

1.  The oxidation induced by antimyeloperoxidase antibodies triggers fibrosis in microscopic polyangiitis.

Authors:  P Guilpain; C Chéreau; C Goulvestre; A Servettaz; D Montani; N Tamas; C Pagnoux; E Hachulla; B Weill; L Guillevin; L Mouthon; F Batteux
Journal:  Eur Respir J       Date:  2010-11-11       Impact factor: 16.671

2.  Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis.

Authors:  Sophia Lionaki; Elizabeth R Blyth; Susan L Hogan; Yichun Hu; Brent A Senior; Caroline E Jennette; Patrick H Nachman; J Charles Jennette; Ronald J Falk
Journal:  Arthritis Rheum       Date:  2012-10

3.  Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis.

Authors:  G S Kerr; T A Fleisher; C W Hallahan; R Y Leavitt; A S Fauci; G S Hoffman
Journal:  Arthritis Rheum       Date:  1993-03

4.  ANCA as a predictor of relapse: useful in patients with renal involvement but not in patients with nonrenal disease.

Authors:  Michael J Kemna; Jan Damoiseaux; Jos Austen; Bjorn Winkens; Jim Peters; Pieter van Paassen; Jan Willem Cohen Tervaert
Journal:  J Am Soc Nephrol       Date:  2014-10-16       Impact factor: 10.121

5.  ANCA and predicting relapse in systemic vasculitis.

Authors:  D R Jayne; G Gaskin; C D Pusey; C M Lockwood
Journal:  QJM       Date:  1995-02

Review 6.  Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis.

Authors:  Xavier Bossuyt; Jan-Willem Cohen Tervaert; Yoshihiro Arimura; Daniel Blockmans; Luis Felipe Flores-Suárez; Loïc Guillevin; Bernhard Hellmich; David Jayne; J Charles Jennette; Cees G M Kallenberg; Sergey Moiseev; Pavel Novikov; Antonella Radice; Judith Anne Savige; Renato Alberto Sinico; Ulrich Specks; Pieter van Paassen; Ming-Hui Zhao; Niels Rasmussen; Jan Damoiseaux; Elena Csernok
Journal:  Nat Rev Rheumatol       Date:  2017-09-14       Impact factor: 20.543

7.  Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritis.

Authors:  C F Franssen; C A Stegeman; W W Oost-Kort; C G Kallenberg; P C Limburg; A Tiebosch; P E De Jong; J W Tervaert
Journal:  J Am Soc Nephrol       Date:  1998-10       Impact factor: 10.121

8.  Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials.

Authors:  Joanna Robson; Helen Doll; Ravi Suppiah; Oliver Flossmann; Lorraine Harper; Peter Höglund; David Jayne; Alfred Mahr; Kerstin Westman; Raashid Luqmani
Journal:  Ann Rheum Dis       Date:  2013-11-15       Impact factor: 19.103

9.  ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis.

Authors:  Javier D Finkielman; Augustine S Lee; Amber M Hummel; Margaret A Viss; Gregory L Jacob; Henry A Homburger; Tobias Peikert; Gary S Hoffman; Peter A Merkel; Robert Spiera; E William St Clair; John C Davis; W Joseph McCune; Andrea K Tibbs; Steven R Ytterberg; John H Stone; Ulrich Specks
Journal:  Am J Med       Date:  2007-07       Impact factor: 4.965

10.  Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors.

Authors:  Anisha Tanna; Laura Guarino; Frederick W K Tam; Beatriz Rodriquez-Cubillo; Jeremy B Levy; Tom D Cairns; Megan Griffith; Ruth M Tarzi; Benjamin Caplin; Alan D Salama; Terence Cook; Charles D Pusey
Journal:  Nephrol Dial Transplant       Date:  2014-07-12       Impact factor: 5.992

View more
  2 in total

1.  The association of 5-year therapeutic responsiveness with long-term renal outcome in IgA nephropathy.

Authors:  Hideo Tsushima; Ken-Ichi Samejima; Masahiro Eriguchi; Takayuki Uemura; Hikari Tasaki; Fumihiro Fukata; Masatoshi Nishimoto; Takaaki Kosugi; Kaori Tanabe; Keisuke Okamoto; Masaru Matsui; Kazuhiko Tsuruya
Journal:  Clin Exp Nephrol       Date:  2022-04-15       Impact factor: 2.617

Review 2.  Neutrophils in ANCA-associated vasculitis: Mechanisms and implications for management.

Authors:  Shangqing Ge; Xingyu Zhu; Qinyao Xu; Junyan Wang; Cheng An; Ying Hu; Fan Yang; Xinyi Wang; Yipin Yang; Shuwen Chen; Ruimin Jin; Haiyan Li; Xinchen Peng; Yue Liu; Junnan Xu; Minhui Zhu; Zongwen Shuai
Journal:  Front Pharmacol       Date:  2022-09-23       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.